<?xml version="1.0" encoding="UTF-8"?>
<p>Further analyses showed that consistent with previous findings [
 <xref rid="pone.0228029.ref002" ref-type="bibr">2</xref>, 
 <xref rid="pone.0228029.ref042" ref-type="bibr">42</xref>, 
 <xref rid="pone.0228029.ref048" ref-type="bibr">48</xref>] all potential N-linked glycosylation sites were conserved in all but one influenza A (H1N1) pdm09 strains circulating in Kenya during 2015/2018 seasons, comparative to respective vaccine strains. All analyzed Kenyan A (H1N1) pdm09 subclade 6B.1 members displayed an additional N-glycosylation at residue sites 162â€“164 attributed to the S162N substitution [
 <xref rid="pone.0228029.ref042" ref-type="bibr">42</xref>]. The potential gain or loss of N-linked glycosylation at HA1 epitope sites can alter influenza virus antigenic properties [
 <xref rid="pone.0228029.ref013" ref-type="bibr">13</xref>, 
 <xref rid="pone.0228029.ref049" ref-type="bibr">49</xref>].
</p>
